The results observed in these and DIO mice may suggest that Leap2 expression in the small intestine, and the ileum, in particular, maybe due to glucose intolerance rather than obesity per se, since this dysmetabolic feature was common to both genetically obese mice and HFHS mice when they showed increase Leap2 mRNA levels. Here, LEAP2 is linked to obesity disorder.